Back to Search Start Over

Biochemical Models of Parkinson's Disease.

Authors :
Boulton, Alan A.
Baker, Glen B.
Juorio, Augusto V.
Heikkila, R. E.
Sonsalla, P. K.
Duvoisin, R. C.
Source :
Drugs as Tools in Neurotransmitter Research; 1989, p351-384, 34p
Publication Year :
1989

Abstract

There are several dopaminergic pathways present in mammalian brain (Ungerstedt, 1971a, b, c, d; Schultz, 1982). Perhaps the most studied of these is the nigrostriatal pathway, which arises from pigmented cell bodies in the zona compacta of the substantia nigra and projects rostrally to the neostriatum (corpus striaturn). Parkinson's disease is a syndrome of diverse etiology that is characterized by a degeneration of the above-mentioned nigrostriatal pathway. It has been estimated that the incidence of parkinsonism in the general population ranges from 100 to 150 cases per 100,000, with the prevalence being considerably greater in an older population sample (Schoenberg, 1987; Yahr, 1977). Biochemical and pathological characteristics of this disease include a greatly diminished neostriatal content of dopamine (DA) and its major metabolites and a marked loss of nerve cells in the zona compacta of the substantia nigra. Additional neuronal systems involved include noradrenergic and cholinergic systems. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISBNs :
9780896031227
Database :
Supplemental Index
Journal :
Drugs as Tools in Neurotransmitter Research
Publication Type :
Book
Accession number :
33149405
Full Text :
https://doi.org/10.1385/0-89603-122-5:351